The healthcare landscape is seeing a shift with the arrival of GLP-1 delivery devices. These cutting-edge formulations offer a potential approach to delivering glucagon-like peptide-1 drugs for individuals battling type 2 diabetes . Instead of injections , a convenient patch placed to the area could release a steady quantity of the substance, poten